Nucelion Therapeutics Private Limited - Company Profile

It is a business services private limited company based in Rangareddy, Telangana, India, established in 2025.
2025 Rangareddy, Telangana, India Active
Last Updated:
Access Report
About Nucelion Therapeutics Private Limited

Nucelion Therapeutics Private Limited, a active private limited company, was established on 19 September 2025 in Rangareddy, Telangana, India. it holds CIN: U21001TS2025PTC204260. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹9.00 Cr.

Formerly known as Nucelion Therapeutics Private Limited. Its leadership includes Krishna Murthy Ella (Nominee Director), Raches Virendradev Ella (Non- Individual Subscriber). It is based at Plot No3 Sp Biotech Park, Turkapally(V)Shameerpet, Rangareddy, Telangana, 500078.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21001TS2025PTC204260

  • Registration Number

    204260

  • Incorporation Date

    19 September 2025

  • Authorized Capital

    ₹10.00 Cr

  • Paid-Up Capital

    ₹9.00 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 9.00 Cr
  • Company Age 9 Months 17 Days
Company report

Nucelion Therapeutics Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Nucelion Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Nucelion Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Krishna Murthy Ella Nominee Director 19 Sep 2025 Current
Raches Virendradev Ella Non- Individual Subscriber 19 Sep 2025 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nucelion Therapeutics.
Nucelion Therapeutics revenue growth over time
Nucelion Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nucelion Therapeutics?

Unlock access to Nucelion Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Nucelion Therapeutics?

Unlock and access historical data on people associated with Nucelion Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nucelion Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nucelion Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nucelion Therapeutics
Recent Activity within the Organization
  • Director Appointment

    Progress on Krishna Murthy Ella was appointed as a Nominee Director was appointed as a Nominee Director on 19 Sep 2025 & has been associated with this company since 9 months 17 days . was documented.

  • Director Appointment

    Progress on Raches Virendradev Ella was appointed as a Non- Individual Subscriber was appointed as a Non- Individual Subscriber on 19 Sep 2025 & has been associated with this company since 9 months 17 days . was documented.

  • Company Incorporation

    Nucelion Therapeutics Private Limited was registered on 19 Sep 2025 with Roc Hyderabad & aged 9 months 17 days as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nucelion Therapeutics Private Limited?

The CIN of Nucelion Therapeutics Private Limited is U21001TS2025PTC204260.

Where is Nucelion Therapeutics Private Limited headquartered?

Nucelion Therapeutics Private Limited is headquartered at Plot No3 Sp Biotech Park, Turkapally(V)Shameerpet, Rangareddy, Telangana, 500078.

When was Nucelion Therapeutics Private Limited incorporated?

Nucelion Therapeutics Private Limited was incorporated on 19 September 2025.

Who are the current directors of Nucelion Therapeutics Private Limited?

The current directors of Nucelion Therapeutics Private Limited are

Is Nucelion Therapeutics Private Limited a listed company?

Nucelion Therapeutics Private Limited is unlisted.

What is the capital structure of Nucelion Therapeutics Private Limited?

The authorized capital of Nucelion Therapeutics Private Limited is ₹10.00 Cr, and the paid-up capital is ₹9.00 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available